NDC 53808-1003
Lamotrigine 25 mg tablet
On the label: State of Florida DOH Central Pharmacy. It's repackaged: State of Florida DOH Central Pharmacy rebottles it from Caraco Pharmaceutical Laboratories, Ltd.'s NDC 51672-4130.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Taro Pharmaceutical Industries Ltd. | Haifa Bay, Israel | Makes it | No problems foundDec 8, 2022 · 7 inspections |
Repackaging site
- State of Florida DOH Central Pharmacy, Location not on file · repackages it
Recalls
- Dec 20, 2019 · Class I · Taro Pharmaceuticals U.S.A., Inc.
Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.
Lots: Lot #: 331771, Exp. June 2021
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Lamotrigine: every company that makes it
- Form
- tablet
- Strength
- 25 mg
- Approval
- ANDA ANDA078525
- On the market since
- Nov 1, 2014
- Package NDCs
53808-1003-1- Official label
- DailyMed (National Library of Medicine), updated Jan 3, 2015
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?